Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1378768 | Bioorganic & Medicinal Chemistry Letters | 2005 | 5 Pages |
Sixteen derivatives of N-acetyl-3-O-methyldopamine (NAMDA), an inhibitor of BH4 synthesis, were designed and synthesized. The ability of these derivatives to inhibit NO and BH4 production by lipopolysaccharide-stimulated BV-2 microglial cells was determined. While NAMDA at 100 μM inhibited NO and BH4 production by only about 20%, its catecholamide 8, indole 23 derivative, 13, and N-acetyl tetrahydroisoquinoline 25 inhibited the NO production by >50% at the same concentration. In particular, 13 and 25 inhibited both NO and BH4 production to similar degrees, which suggested that these compounds might inhibit NO production by blocking BH4-dependent dimerization of the newly synthesized iNOS monomer.
Graphical abstractSixteen derivatives of NAMDA (1), an inhibitor of BH4 synthesis, were designed and synthesized.Figure optionsDownload full-size imageDownload as PowerPoint slide